MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

39.20 -0.82 (-2.05%)
Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
48 49 Next >
News headline image
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery
From Gibbs Mura
Via Business Wire
News headline image
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth ↗
Hims & Hers stock fell sharply Tuesday after the company missed Q2 revenue estimates, despite strong growth and reaffirmed guidance. 
Via The Motley Fool
Hims & Hers Tumbles After-Hours On Q2 Miss, GLP-1 Slowdown — But Retail Traders Eye Bargain Entry ↗
Via Stocktwits
News headline image
HIMS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Earnings Season Wrap-Up: Tech Giants Shine, Others Face Mixed Results
The latest earnings season, spanning late July and early August 2025, has painted a vivid picture of a bifurcated market, where the titans of technology continue to defy gravity, largely propelled by... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers
The U.S. stock market experienced a turbulent start to August 2025, marked by significant declines for several prominent companies. This downturn, following a volatile end to July, has left investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today ↗
Via Stocktwits
News headline image
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday? ↗
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. 
Via Benzinga
Topics Economy Government
News headline image
Hims & Hers Stock Is Trading Lower Tuesday: What's Going On? ↗
 
Via Benzinga
News headline image
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say ↗
Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, including regulatory complexity. 
Via Benzinga
News headline image
Why Hims & Hers Health Stock Just Dropped ↗
Hims & Hers stock just got cheaper -- and it's still too expensive to buy. 
Via The Motley Fool
News headline image
Why Did Hims & Hers Stock Crash and Then Recover After Earnings? ↗
HIMS stock was down 13% after the company reported earnings. 
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
News headline image
3 Stocks to Hold for 20 Years ↗
These stocks have decades of compounding growth ahead. 
Via The Motley Fool
News headline image
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Lost Money on Hims &amp; Hers Health, Inc. (HIMS)? Join Class Action Suit Seeking Recovery - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (3 Ratings) ↗
 
Via Benzinga
News headline image
Novo Nordisk Stock Sinks—But Is a Bottom Finally In? ↗
Novo Nordisk stock is down over 43% in 2025 as investors weigh weak guidance, GLP-1 competition, and the potential for a rebound after earnings 
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On? ↗
Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue on Monday that missed Wall Street expectations. 
Via Benzinga
News headline image
Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today ↗
Major U.S. indices ended Monday in the green with the Dow Jones Industrial Average rising 1.3% higher at 44,173.64. 
Via Benzinga
Topics Stocks
News headline image
Hims & Hers (HIMS) Q2 Revenue Jumps 73% ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Monday? ↗
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%
Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 72.6% year on year to $544.8 million. On the other hand, the company... 
Via StockStory
News headline image
Hims & Hers Health Stock Tumbles On Q2 Earnings As Revenue Comes Up Short, Company Sees 'Exciting Period Of Growth' Ahead ↗
Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million. 
Via Benzinga
News headline image
IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss ↗
The company reiterated its sales outlook for the year, despite coming in with lighter-than-expected second-quarter sales. 
Via Investor's Business Daily
Topics ETFs Earnings
News headline image
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story